Congress Urged to Include Biologics in Drug Shortage Mandates for Pharma Companies
Biologics, like small-molecule drugs, may soon be subject to early shortage notification requirements if a group of stakeholders convinces lawmakers to include them in pending user fee authorization bills.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.